PH1 OF A KIND
Filed: June 26, 2019
Promoting public awareness about primary hyperoxaluria among affected individuals and their families
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 88489381
OXLUMO
Filed: August 13, 2019
Pharmaceutical preparations for the treatment of primary hyperoxaluria
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 88576813
ONPATTRO
Filed: October 1, 2019
Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmaceutical preparations for the…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 88637585
FAMATTRY
Filed: October 2, 2019
Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmaceutical preparations for the…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 88639313
KIRNAKO
Filed: October 2, 2019
Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, infectious, genetic and cardio…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 88639647
OFREMKO
Filed: October 2, 2019
Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, infectious, genetic and cardio…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 88639659
OTETREVI
Filed: October 2, 2019
Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, infectious, genetic and cardio…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 88639665
SISRELNA
Filed: October 2, 2019
Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, infectious, genetic and cardio…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 88639681
Image Trademark
Filed: February 15, 2020
Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmaceutical preparations for the…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 88799212
Image Trademark
Filed: February 15, 2020
Pharmaceutical preparations for the treatment of primary hyperoxaluria
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 88799213
Image Trademark
Filed: February 15, 2020
Pharmaceutical preparations for the treatment of porphyria
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 88799215
TAKE ON PH1
Filed: February 19, 2020
Promoting public awareness about primary hyperoxaluria among affected individuals and their families
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 88803039
CONTTRIBUTE
Filed: April 15, 2020
Maintaining a clinical registry database for patients with mutations of the transthyretin gene; maintaining a registry on…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 88872680
RNAI EVIDENCE
Filed: August 28, 2020
Maintaining a clinical registry database for patients with genetic mutations; maintaining a registry on the clinical outcomes…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 90145170
AMVUTTRA
Filed: September 1, 2020
Pharmaceutical preparations for the treatment of amyloidosis
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 90151672
AMVYTTRA
Filed: September 15, 2020
Pharmaceutical preparations for the treatment of amyloidosis
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 90182464
ELEVATE
Filed: April 23, 2021
Maintaining a clinical registry database for patients with genetic mutations that cause enzyme defects and acute hepatic…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 90667344
BONAPH1DE
Filed: April 23, 2021
Maintaining a clinical registry database for patients with inherited disorders of the liver and primary hyperoxaluria; maintaining…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 90667433
BEHIND THE STONE
Filed: April 23, 2021
Promoting public awareness about primary hyperoxaluria among affected individuals and their families
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 90667583
TAKE ON PH1
Filed: April 30, 2021
Promoting public awareness about primary hyperoxaluria among affected individuals and their families
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 90683589
REVERSIR
Filed: May 7, 2021
Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV, hepatitis A, hepatitis B,…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 90696853
IKARIA
Filed: May 28, 2021
Pharmaceuticals having a particularly long duration of effect as compared to others of the same chemical class
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 90741603
AMVUTTRA
Filed: October 3, 2021
Pharmaceutical preparations for the treatment of amyloidosis
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 97057473
AMVUTTRA
Filed: October 3, 2021
Pharmaceutical preparations for the treatment of amyloidosis
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 97057480
Image Trademark
Filed: October 3, 2021
Pharmaceutical preparations for the treatment of amyloidosis
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 97057483
POWER OVER AHP GLOBAL PERSPECTIVES ON LIVING WITH ACUTE HEPATIC PORPHYRIA
Filed: October 19, 2021
Promoting public awareness about porphyria among affected individuals and their families
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 97081007
POWER OVER AHP GLOBAL PERSPECTIVES ON LIVING WITH ACUTE HEPATIC PORPHYRIA
Filed: October 19, 2021
Promoting public awareness about porphyria among affected individuals and their families
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 97081087
ALNYLAM ASSIST
Filed: January 26, 2022
Providing information on financial assistance programs for the access of pharmaceutical treatments and therapies; reimbursement…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 97239777
SISRELNA
Filed: September 20, 2022
Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, infectious, genetic and cardio…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 97599387
OTETREVI
Filed: September 20, 2022
Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, infectious, genetic and cardio…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 97599396
OFREMKO
Filed: September 20, 2022
Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, infectious, genetic and cardio…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 97599403
KIRNAKO
Filed: September 20, 2022
Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, infectious, genetic and cardio…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 97599408
FAMATTRY
Filed: September 20, 2022
Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, infectious, genetic and cardio…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 97599416
THE BRIDGE
Filed: March 30, 2023
Advertising services to promote public awareness of medical conditions; advertising services to promote public awareness…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 97865335
RNAISCIENCE
Filed: April 10, 2024
Providing scientific information in the field of biopharmaceuticals
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 98493171
RNAI REVOLUTION
Filed: June 17, 2024
Scientific research; scientific research in the fields of pharmaceuticals and medicine, chemical and medical laboratories…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 98603908
RNAI REVOLUTION
Filed: June 17, 2024
Scientific research; scientific research in the fields of pharmaceuticals and medicine, chemical and medical laboratories…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 98603913
DISRUPTING DISEASE
Filed: June 19, 2024
Scientific research; scientific research in the fields of pharmaceuticals and medicine, chemical and medical laboratories…
Owned by: Alnylam Pharmaceuticals, Inc.
Serial Number: 98609018
